Acure Pharma AB
Records under this name other than patents Acure Pharma AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Acure Pharma AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,372,878 | Aminoguanidines as melanocortin receptor ligands Formerly held Lapsed on the fee record Ended Feb 12, 2021 · From the USPTO record | Lapsed on the fee record | Ended Feb 12, 2021 | From the USPTO record |
| US 8,309,609 | Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands Formerly held Lapsed on the fee record Ended Nov 13, 2020 · From the USPTO record | Lapsed on the fee record | Ended Nov 13, 2020 | From the USPTO record |
| US 8,227,502 | Amides acting on the adenosine receptors Formerly held Lapsed on the fee record Ended Jul 24, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jul 24, 2020 | From the USPTO record |
| US 8,148,429 | Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands Formerly held Lapsed on the fee record Ended Apr 3, 2020 · From the USPTO record | Lapsed on the fee record | Ended Apr 3, 2020 | From the USPTO record |
| US 7,153,881 | Compounds acting as melanocortin receptor ligands Formerly held Lapsed on the fee record Ended Dec 26, 2018 · From the USPTO record | Lapsed on the fee record | Ended Dec 26, 2018 | From the USPTO record |
| US 6,518,246 | Pharmaceutical composition and method for the treatment of neoplastic cells Lapsed on the fee record Ended Feb 11, 2015 · From the USPTO record | Lapsed on the fee record | Ended Feb 11, 2015 | From the USPTO record |